期刊文献+

自制肝复康胶囊辅助治疗HCC临床观察 被引量:2

The effects of TACE combined with Chinese medicine Ganfukang to the hepatocelluar carcinoma
下载PDF
导出
摘要 目的探讨自制肝复康胶囊辅助治疗原发性肝细胞肝癌(HCC)的疗效。方法将100例经临床及 影像学、血清学、活组织检查确诊为HCC的患者随机分成A、B两组各50例,其年龄、性别、病情等无显著差异(P >0.05),入院后A、B两组均行肝动脉化疗栓塞术(TACE),术后两组均予常规治疗,A组加服肝复康胶囊,观察 两组疗效。结果A组患者的的生存率、血清AFP下降率及各项免疫因子水平等均优于B组。结论 TACE术 后口服肝复康胶囊,可提高HCC患者生活质量及免疫力,延长生存时间。 Objective To evaluate the effect of the hepatocellular carcinoma treated by TACE combined with Chinese medicine Ganfukang. Methods 100 cases of HCC (diagnosed by percutaneous biopsy under the guide of CT or B-ultrasound) were divided randomly into two groups. Group B(50 cases) were treated by TACE alone,Group A(50 cases) were treated by TACE and Chinese medicine Ganfukang. The efficacy of two groups was compared according to the level of CD3 、CD4、CD8、NK cell. Results The clinical information showed that there were significant differences in the survival rate, size of the tumor,changes of AFP level and the immunity, the ability of NK cell between the two groups(P<0. 01). Conclusions Chinese medicine Ganfukang can improve the immunity and prolong the survival time of HCC treated by TACE.
出处 《山东医药》 CAS 北大核心 2005年第2期13-14,共2页 Shandong Medical Journal
基金 山东中医药管理局资助课题(2001-2-777)
关键词 肝复康胶囊 原发性肝细胞肝癌 生活质量 免疫力 中药制剂 Hepatocellular Chemoembolization T lymphocyte NK cell
  • 相关文献

参考文献5

  • 1Tanaka K,Nakamara S,Namata,et al.The long-term efficacy of combined trans-catheter arterial emobolization and precutaneous ethanol injection in the treatment of patients with large hepatocellular carinoma and cirrhosis.Cancer,1998,32:78~85.
  • 2Matsuo N,Uchida H,Sakaguchi H,et al.Optimal lipoidol volume in transcatheter arterial chemoembolization therapy for hepatocellular carcinoma:study based on lipoidol accumulation patterns and histopathologic findings.Semin Oncol,1997,24:61~70.
  • 3Bartolozzi C,Lencioni R,Caramella D,et al.Hepatocellular carcinoma:CT and MR features after transactheter arterial embolization and precutaneous enthanol injection.Radiology,1994,191:123~128.
  • 4吴沛宏,张福君,赵明,范卫君,黄金华,顾仰葵,李立.肝动脉栓塞化疗联合CT导向射频消融术治疗中、晚期肝癌的评价[J].中华放射学杂志,2003,37(10):901-904. 被引量:111
  • 5李东复,葛焕琦,王树和,杨海山,刘玉珠.肝癌患者肝动脉灌注IL-2、TNF-α治疗前后机体免疫状态的研究[J].中国肿瘤生物治疗杂志,1998,5(1):46-48. 被引量:7

二级参考文献10

  • 1李东复,王秀清,宋玉芳,王艳芬,杨海山,杨淑芹,王大伟,陈光利,常艳华.42例肝癌患者外周血T淋巴细胞亚群变化与sIL—2R水平关系的研究[J].中国免疫学杂志,1993,9(5):313-314. 被引量:9
  • 2Rhim H,Dodd GD 3rd.Radiofrequency thermal ablation of liver tumors(Review). J Clin Ultrasound, 1999,27:221-229.
  • 3Siperstein AE,Gitamiraki A.History and technological aspecta of radiofrequency themoablation (Review).Cancer J,2000,6(Supple 4):S293-S303.
  • 4Bartolozzi C,Lencioni R,Caramella D, et al. Hepatocellular carcinoma:CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology, 1994,191:123-128.
  • 5Goldberg SN, Kamel IR, Krudkal JB, et al. Radiofrenquency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy.AJR ,2002,179:93-101.
  • 6Curdey SA, Lzzo F, Delrio P,et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies:results in 123 patients. Am Surg,1990,230:1-8.
  • 7Izzo F, Barnett C Jr, Curley SA. Radiofrequency ablation of primary and metastatic malignant liver tumors(Review). Adv Surg, 2001,35:225-250.
  • 8宋玉芳,李东复,杨丽,肖红,李兴华,王艳芬,张国荣,董丽.42例消化性溃疡患者外周血T细胞亚群的测定结果[J]中国免疫学杂志,1991(02).
  • 9Aleta Keong,Jean Herman,Arthur R. Rabson. Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) depresses natural killer (NK) cell activity[J] 1983,Cancer Immunology Immunotherapy(3):183~187
  • 10范卫君,赵明,吴沛宏,张福君,黄金华,李立,徐志斌,莫运仙,顾仰葵.经皮射频消融术在肝脏肿瘤治疗中的临床价值[J].中华放射学杂志,2002,36(4):313-316. 被引量:47

共引文献116

同被引文献58

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部